Hemodynamic instability after elective carotid stenting: frequency and risk factors
Dan Popescu1, Athena Mergeani, Ovidiu Alexanrdu Bajenaru
1Neurology Clinic, Bucharest University Emergency Hospital, Romania.
Insights
Hemodynamic instability, including hypotension and bradycardia, affects a minority of patients undergoing carotid stenting. Risk factors include extensive manipulation and beta-blocker use, but instability is not linked to neurological complications.
Area of Science:
- Neurology
- Cardiovascular Surgery
- Interventional Neuroradiology
Background:
- Carotid artery stenting (CAS) can trigger hemodynamic instability due to baroreceptor dysfunction.
- Identifying risk factors for hemodynamic instability is crucial for patient safety during CAS.
Purpose of the Study:
- To determine the frequency and risk factors of hemodynamic instability (hypotension/bradycardia) during elective CAS.
- To assess the association between hemodynamic instability and neurological complications post-CAS.
Main Methods:
- Retrospective analysis of 130 patients undergoing elective CAS with cerebral protection.
- Defined hemodynamic instability as a systolic blood pressure drop >30 mmHg and/or bradycardia.
- Identified risk factors including stenosis characteristics and pre-procedure medications.
Main Results:
- 20% of patients experienced hemodynamic instability despite adequate fluid management.
- No significant association was found between hemodynamic instability and neurological complications (9% incidence).
- Extensive manipulation, long stenosis at bifurcation, and beta-blocker use were associated with increased risk.
Conclusions:
- Hemodynamic instability is relatively infrequent after CAS.
- Patients with long stenoses near the bifurcation or on beta-blockers are at higher risk.
- Intravenous fluids did not prevent periprocedural hypotension.
Abstract:
The objective of this study is to investigate the frequency and risk factors for hemodynamic instability (hypotension and/or bradycardia) in response to elective carotid stenting and their association with neurological complications. Carotid artery stenting implies instrumentation of the carotid bulb where the baroreceptors are placed and therefore baroceptor's dysfunction may provoke hemodynamic instability. The study started in the Neurology Clinic of the Emergency University Hospital, Bucharest as a retrospective analysis of the charts of 130 patients (110 men with mean age of 55 years) who underwent elective carotid artery stenting with cerebral protection for high-grade (>70%) symptomatic internal carotid artery stenosis. By hemodynamic instability one can understand the drop in systolic blood pressure of more than 30mmHG and bradycardia. 20% of patients had a drop in systolic blood pressure beyond 30 mmHg and/or bradycardia despite an adequate fluid balance. We did't use atropine as premedication before carotid stenting. There was no need for aggressive resuscitation (dopamine) and none of the patients with bradycardia needed pacemaker support. Neurological complications (transient ischemic attack, minor stroke, major stroke) occurred in 9% of patients and were not significantly associated with hemodynamic instability. Extensive carotid artery manipulation, a long stenosis situated at the bifurcation and the prior use of beta-blockers were associated with an increased adjusted risk for hypotension or bradycardia. Hemodynamic instability due to hypotension and bradycardia in response to carotid artery stenting occurs in a relatively low proportion of patients. Patients who had a long (over 6 mm) stenosis situated near the common carotid artery's bifurcation and therefore underwent extensive carotid manipulation or those who were on beta-blockers were at high risk for hypotension or bradycardia. The preadministrations of intravenous fluids didn't prevent the periprocedural hypotensive response.
Related Concept Videos
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Transient Ischemic Attack l: Introduction
Aortic Regurgitation I: Introduction
Cardiac Catheterization IV: Nursing Management
Hemorrhagic Stroke ll: Pathophysiology
